
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark, a leading player in the tissue and hygiene industry, has a diversified product portfolio that includes well-known brands such as Huggies, Kleenex, and Cottonelle, contributing to over half of its sales from personal care and approximately one-third from consumer tissue products. The company has a strong geographical presence, generating just over 50% of its sales in North America and more than 10% in Europe, with additional significant revenue streams from Asia and Latin America. With a robust innovation pipeline expected for 2026, Kimberly-Clark is well-positioned to leverage advanced technologies to enhance its product offerings and efficiently cascade innovations down the value tiers, supporting its continued growth in the evolving market.
Bears say
Kimberly-Clark is facing a negative outlook due to projected organic sales declines, with a significant estimate of -4.0% for the third quarter of 2025, a stark contrast to prior expectations of +4.5%. Additionally, the company has experienced a -2.7% decline in measured retail sales in the United States for the same period, further highlighting the ongoing challenges in its key markets. The downward revisions in earnings per share forecasts for fiscal years 2025 and 2026, from $7.60 to $7.41 and from $8.00 to $7.85 respectively, reflect deteriorating financial performance expectations.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares